Evolus, Inc. (EOLS)

Evolus Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-60	-61.69	-74.41	-46.81	-163.01	-90.03
Depreciation & Amortization	6.01	5.87	4.5	6.31	7.68	5.01
Share-Based Compensation	18.24	16.46	10.83	9.58	10.58	9.52
Other Operating Activities	11.71	5.35	-25.83	-2.47	86.88	-17.87
Operating Cash Flow	-24.04	-34.01	-84.91	-33.39	-57.87	-93.38
Capital Expenditures	-1.91	-1.63	-2.94	-0.97	-3.14	-4.57
Change in Investments	0	0	0	5	15.33	-18.87
Investing Cash Flow	-1.91	-1.63	-2.94	4.03	12.19	-23.43
Share Issuance / Repurchase	47.69	0.22	0.54	103.99	0	75.77
Debt Issued / Paid	49.95	49.95	-0.5	-27.63	39.48	70.66
Other Financing Activities	-6.06	-5.54	-4.19	-3.31	-1.13	-12.88
Financing Cash Flow	91.59	44.64	-4.15	73.05	38.35	133.55
Exchange Rate Effect	-0.14	-0.09	-0.34	0	0	0
Net Cash Flow	65.5	8.92	-92.33	43.69	-7.33	16.73
Free Cash Flow	-25.95	-35.64	-87.85	-34.36	-61.01	-97.95
Free Cash Flow Margin	-11.81%	-17.63%	-59.11%	-34.47%	-107.90%	-280.46%
Free Cash Flow Per Share	-0.44	-0.63	-1.57	-0.69	-1.81	-3.47

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).